The full scope at Ascend includes: Obesity and overweight with comorbidities - full workup, GLP-1 candidacy assessment, lifestyle integration Type 2 diabetes with weight management goals - GLP-1 medications often address both indications simultaneously Hypertension tied to weight - coordinated medication review and lifestyle work Dyslipidemia and metabolic syndrome - lipids often improve markedly with weight loss Prediabetes - HbA1c 5.7-6.4% range, where intervention can prevent progression Fatty liver disease (MASLD) - weight loss is the primary intervention
For example, a 2023 study showed that in the next 3 hours after consuming carbs, there was a 65% increase in GLP-1 , which is considerably more than in the placebo group**
Some studies have reported positive results for these diseases, exploring the potential for healthcare professionals
Additional Resources Getting Started on The Leptin Diet How Digestive Problems Prevent Weight Loss The Leptin Diet Weight Loss Challenge #2 Why Toxins and Waste Products Impede Weight Loss The Leptin Diet Weight Loss Challenge #3 Unclog Your Liver & Lose Abdominal Fat- Leptin Diet Weight Loss Challenge #6 GLP-1 Drugs Linked with Bone Loss, Softer Bones and Gout GLP-1 Drugs Lead to Nutrient Deficiencies GLP-1 Weight Loss Meds Cause Significant Muscle Loss and SIBO Supplements to Boost GLP-1 Naturally How to Boost Your Satiety Hormone and Curb Food Cravings Colon Cancer Skyrocketing in Young People Muscle Strength and Aging: How to Stay Strong Hidden Obesogens in Foods, Beverages, and Environment Disrupt Metabolism

Best for: Loose abdominal skin Crepey upper arms or thighs Overall texture and tone improvement on larger body areas EMSCULPT NEO: Build Muscle, Burn Fat, Restore Definition Many GLP1 patients lose some muscle mass alongside fat, which can contribute to a softer, less defined shape or a skinny fat appearance